<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD002280-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD002280-sec-0008"></div> <div class="table" id="CD002280-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Fluoride gel compared with placebo or no treatment for caries prevention in children and adolescents</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> Children and adolescents </p> <p><b>Settings:</b> Community (predominantly schools) </p> <p><b>Intervention:</b> Fluoride gel </p> <p><b>Comparison:</b> Placebo or no treatment </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="3" class="headercell"> <p><b>No of Participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="3" class="headercell"> <p><b>Quality of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>No treatment/placebo</b> </p> </th> <th scope="col" align="" valign="bottom" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Fluoride gel</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Changes in caries on the surfaces of permanent teeth,</b> measured by </p> <p>D(M)FS increment ‐ nearest to 3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean increment ranged across control groups from 0.2 to 11.5, median 1.7</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean increment in the intervention groups was<br><b>0.27</b> (95% CI 0.18 to 0.37) <b>lower</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>PF</b><sup>1</sup> 28% (95% CI 19% to 36%) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8479</p> <p>(25 studies)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>moderate</b> </p> <p>⊕⊕⊕⊝<sup>2</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Changes in caries on the surfaces of primary teeth,</b> measured by d(m)fs increment ‐ nearest to 3 years </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean increment ranged across control groups from 1.8 to 5.1, median 1.8</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean increment in the intervention groups was <b>0.52</b> (95% CI 0.17 to 0.88) <b>lower</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>PF</b><sup>1</sup> 20% (95% CI 1% to 38%) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1254</p> <p>(3 studies)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>low</b> </p> <p>⊕⊕⊝⊝<sup>3</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Signs of acute toxicity ‐ nausea, vomiting</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>0 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>10 per 1000</b><br>(10 fewer to 20 more) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RD</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>490<br>(2 studies) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br>v<b>ery low</b><sup>4,5,</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risks were calculated from pooled risk differences (RD: 0.01 (95% ‐0.01, 0.02)</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> was the range and median in the control groups of the studies included in the review. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> confidence interval; <b>D(M)FS:</b> decayed, (missing) and filled permanent surfaces; <b>PF:</b> prevented fraction; <b>RD:</b> risk difference; <b>RR:</b> risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>PF = 1 ‐ (mean increment in control group/mean increment in treatment group) (expressed as percentages). PF values between 1% to 10% are considered to be a small effect; between 10% to 20%, a moderate effect; values above 20% are considered a large or substantial effect. </p> <p><sup>2</sup> Quality of evidence was downgraded because of the limitations in study design (at least 85% of information is from studies with unclear sequence generation or allocation concealment or both; about 50% are from studies with no placebo use). Although there was high statistical heterogeneity in this outcome, it was not further downgraded for inconsistency as results consistently showed a large clinical effect in caries reduction. </p> <p><sup>3</sup> More than 70% of information comes from a study at low risk of bias for key domains of sequence generation, allocation concealment, and blinding. However, evidence was downgraded twice because only 3 out of 28 studies reported this information; there is concern about publication bias, imprecision of results and the relevance of this outcome to clinical practice. </p> <p><sup>4</sup> Trials either had unclear or high risk of bias in sequence generation and allocation concealment.<br><sup>5</sup> Information only available from two trials. </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
